The stock price of Park Ha Biological Technology Co Ltd (NASDAQ: PHH) has surged by 1421725 when compared to previous closing price of 26.57, but the company has seen a 52.07% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-06-16 that SAN FRANCISCO–(BUSINESS WIRE)–PHH Mortgage, one of the largest mortgage servicers in the U.S., and a subsidiary of Onity Group Inc. (NYSE: ONIT), is expanding its partnership with Blend Labs, Inc. (NYSE: BLND) to deliver faster, more seamless refinance and home equity experiences for borrowers. PHH Mortgage has expanded its use of Blend’s technology platform, already powering its mortgage lending operations, to now include Rapid Refi and Rapid Home Equity. As part of its ongoing digital trans.
Is It Worth Investing in Park Ha Biological Technology Co Ltd (NASDAQ: PHH) Right Now?
The price-to-earnings ratio for Park Ha Biological Technology Co Ltd (NASDAQ: PHH) is above average at 520.03x. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for PHH is 4.82M, and at present, short sellers hold a 1.37% of that float. The average trading volume of PHH on June 24, 2025 was 410.29K shares.
PHH’s Market Performance
The stock of Park Ha Biological Technology Co Ltd (PHH) has seen a 52.07% increase in the past week, with a 107.23% rise in the past month, and a 123.37% gain in the past quarter. The volatility ratio for the week is 2.81%, and the volatility levels for the past 30 days are at 6.03% for PHH. The simple moving average for the past 20 days is 63.50% for PHH’s stock, with a 178.20% simple moving average for the past 200 days.
PHH Trading at 91.96% from the 50-Day Moving Average
After a stumble in the market that brought PHH to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 13.20% of gains for the given period.
Stock Fundamentals for PHH
Current profitability levels for the company are sitting at:
- 0.33 for the present operating margin
- 0.92 for the gross margin
The net margin for Park Ha Biological Technology Co Ltd stands at 0.2. The total capital return value is set at 0.51. Equity return is now at value 38.00, with 17.89 for asset returns.
Based on Park Ha Biological Technology Co Ltd (PHH), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 13.66.
Currently, EBITDA for the company is 0.82 million with net debt to EBITDA at -0.58. When we switch over and look at the enterprise to sales, we see a ratio of 333.21. The receivables turnover for the company is 2.15for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.15.
Conclusion
In summary, Park Ha Biological Technology Co Ltd (PHH) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
